Published in Physician Law Weekly, September 1st, 2004
Patient groups and some members of Congress had pushed the National Institutes of Health to take the unprecedented action, arguing it was warranted under a special law because Norvir's discovery was partially funded by taxpayer dollars.
"The issue of drug pricing has global implications and thus is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.